You are here

US drug giant Amgen opens first next-gen facility in Tuas

Mr Lim (in purple tie) at the 120,000 square foot Tuas plant on Thursday, accompanied by Robert Bradway, Amgen chairman and chief executive officer, and Kimball Hall (extreme right), Amgen vice-president, manufacturing.


AMERICAN drug-maker Amgen expects to roll out its products for treating osteoporosis and bone cancers from its new plant in Tuas by the end of 2016. The S$200 million plant in Tuas Biomedical Park is the first next-generation biomanufacturing facility in the world, and is the...